Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized placebo-controlled dose-ranging study of PF-04236921 in systemic lupus erythematosus
KCT0000909Phase 2Active, not recruiting
- Sponsor
- Pfizer
- Start
- Dec 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pacibekitug in systemic lupus erythematosus (SLE) (4 arms), sponsored by Pfizer. Started Dec 2011; status: active, not recruiting.
02
Drugs
pacibekitug
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on KCT0000909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000909.